Blood protein fingerprint may reveal lung disease secrets

NCT ID NCT00793676

Completed Knowledge-focused Sponsor: University Hospital, Strasbourg, France Source: ClinicalTrials.gov ↗

First seen Jan 24, 2026 · Last updated Apr 30, 2026 · Updated 10 times

Summary

This study looked at whether a family of proteins called GPCRs, found on the surface of cells, could be used as biomarkers to help diagnose or track chronic lung diseases like asthma and COPD. Researchers analyzed blood samples from 205 people (healthy volunteers and patients) to see if these proteins change in disease. The goal was to create a GPCR "identity card" for each disease, which might one day help doctors choose treatments or monitor disease progression.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Antoine Magnan

Nantes, 44035, France
Hospital

Colmar, 68024, France
Pascal Chanez

Marseille, 13008, France
University Hospital

Montpellier, 34295, France
University Hospital, Strasbourg, France

Strasbourg, 67000, France

Conditions

Explore the condition pages connected to this study.

ASTHMA COPD